Highmark, UPMC cut deals with Butler Health System
Highmark Inc. and UPMC have struck separate deals with Butler Health System to bring additional medical services to the system.
Highmark, the state's largest health insurer, hired two neurologists from UPMC who will work at Butler Memorial Hospital in a new practice, the PA Brain and Spine Institute, Highmark said.
Michael Horowitz and Richard Spiro were employed at UPMC Presbyterian before joining Highmark, which is building a health system to compete with UPMC, the region's largest hospital network.
Horowitz worked for UPMC for 19 years, most recently as its director of vascular and endovascular neurosurgery and director of the Center for Cranial Nerve Disorders. Spiro spent 14 years at UPMC and was director and chief of neurological spine surgery.
“We seek out needed services, bring the best expertise to this region and we are dedicated to providing these services in the most convenient manner possible for patients that look to us for their care,” Ken DeFurio, Butler Health CEO, said in a written statement.
Meanwhile, Butler Health and UPMC Cancer Center formed a joint venture cancer center and acquired Butler Radiation Oncology Associates. The practice's two radiation oncologists, Drs. Victor Onufrey and Hung-Chi Ho, are employed by Butler Health.
“We are excited about this collaborative relationship with Butler Health System because it will result in wider access to cancer care and patients will benefit from this improved access,” said Dwight Heron, vice chairman for clinical affairs and director of radiation services for UPMC Cancer Center.
Alex Nixon is a staff writer for Trib Total Media. He can be reached at 412-320-7928.
Add Alex Nixon to your Google+ circles.
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.
- Stop neighbors from stealing your Internet
- Small stores take big gamble by not upgrading credit card readers
- Amazon raises bar for other retailers with same-day delivery
- Yahoo investors losing patience with ‘star’ CEO Marissa Mayer
- Mall stores required to open for Thanksgiving
- Shopping beacons join list of ‘next big thing’ disappointments
- Signs of steady U.S. economy: Pay, home sales up, unemployment applications down
- Many Black Friday deals not worth the hassle
- Pfizer acquires Allergan in $160B deal
- Nutritional supplement makers, led by GNC, want to create voluntary safety standards
- Black Friday loosens its hold on the holiday season